08:00 , Jan 2, 2001 |  BC Week In Review  |  Clinical News

Beta-lactamase inhibitors regulatory update

Research Corp. Technologies (Tucson, Ariz.), which formed AlamX along with Southern Methodist University (Dallas, Texas), received U.S. Patent No. 6,156,745 covering penicillin derivatives that inhibit classes of beta-lactamase enzymes, which AlamX said contribute to antibiotic...